seqWell
Roger Schaller has over 20 years of experience in the biotech and diagnostics industry. Roger began their career in 2000 as a Senior Director of Global Sales and Marketing and Director of Business Development at Cepheid. In 2006, they moved on to Affymetrix, where they held the position of Senior Director of Global Business and Sales Development for MDx. In 2013, they joined RainDance Technologies as Business Leader for Sequencing. In 2017, they were Vice President of Business Development, Marketing, and Sales at Coyote Bioscience co., Ltd. In 2018, they became Chief Operating Officer and Vice President of Business Development at Coyote Bioscience USA. In 2020, they held the position of Vice President of Business Development at Promex Industries Inc. In 2021, they were Executive Vice President of Commercial Operations at Marizyme, Inc. and Vice President of Business Development at seqWell. Additionally, they have served as an Advisor and Chief Operating Officer at Integrated Nano-Technologies in Rochester, NY since 2019.
Roger Schaller's education history includes attending High School from 1968 to 1972, where they earned their 12th grade diploma. Roger then attended Illinois State University from 1972 to 1976, where they earned a BS in Biology, Chemistry, and Photography. Additionally, they attended Illinois State University from 1976 to 1977, where they completed an internship in Medical Technology and earned a BS.
This person is not in any offices
seqWell
seqWell was created to revolutionize NGS library prep to unlock the full potential of today’s DNA sequencing instruments. Its plexWell™ platform is a transformative library prep technology that allows for simple, scalable multiplexing of 100s to 1000s of samples without time- and cost-consuming normalization.